Renaissance Technologies’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-7,200
| Closed | -$53K | – | 4547 |
|
2022
Q3 | $53K | Sell |
7,200
-5,637
| -44% | -$41.5K | ﹤0.01% | 3746 |
|
2022
Q2 | $159K | Buy |
12,837
+8,211
| +177% | +$102K | ﹤0.01% | 3734 |
|
2022
Q1 | $77K | Buy |
4,626
+75
| +2% | +$1.25K | ﹤0.01% | 3838 |
|
2021
Q4 | $296K | Sell |
4,551
-109
| -2% | -$7.09K | ﹤0.01% | 3349 |
|
2021
Q3 | $319K | Sell |
4,660
-100
| -2% | -$6.85K | ﹤0.01% | 3062 |
|
2021
Q2 | $332K | Sell |
4,760
-6,805
| -59% | -$475K | ﹤0.01% | 3111 |
|
2021
Q1 | $759K | Buy |
11,565
+3,597
| +45% | +$236K | ﹤0.01% | 2734 |
|
2020
Q4 | $458K | Sell |
7,968
-1,048
| -12% | -$60.2K | ﹤0.01% | 2859 |
|
2020
Q3 | $536K | Buy |
9,016
+5,334
| +145% | +$317K | ﹤0.01% | 2792 |
|
2020
Q2 | $477K | Buy |
+3,682
| New | +$477K | ﹤0.01% | 2898 |
|
2019
Q4 | – | Sell |
-242
| Closed | -$29K | – | 3817 |
|
2019
Q3 | $29K | Buy |
+242
| New | +$29K | ﹤0.01% | 3358 |
|
2017
Q2 | – | Sell |
-61
| Closed | -$75K | – | 3421 |
|
2017
Q1 | $75K | Sell |
61
-262
| -81% | -$322K | ﹤0.01% | 3111 |
|
2016
Q4 | $130K | Buy |
323
+79
| +32% | +$31.8K | ﹤0.01% | 3063 |
|
2016
Q3 | $100K | Buy |
244
+88
| +56% | +$36.1K | ﹤0.01% | 3180 |
|
2016
Q2 | $76K | Buy |
+156
| New | +$76K | ﹤0.01% | 3198 |
|